Frydrychowicz, M.; Telec, M.; Anioła, J.; Kazmierski, R.; Chowaniec, H.; Dworacki, G.; Wojtasz, I.; Kozubski, W.; Łukasik, M.
The Alteration of Circulating Invariant Natural Killer T, γδT, and Natural Killer Cells after Ischemic Stroke in Relation to Clinical Outcomes: A Prospective Case–Control Study. Cells 2024, 13, 1401.
https://doi.org/10.3390/cells13161401
AMA Style
Frydrychowicz M, Telec M, Anioła J, Kazmierski R, Chowaniec H, Dworacki G, Wojtasz I, Kozubski W, Łukasik M.
The Alteration of Circulating Invariant Natural Killer T, γδT, and Natural Killer Cells after Ischemic Stroke in Relation to Clinical Outcomes: A Prospective Case–Control Study. Cells. 2024; 13(16):1401.
https://doi.org/10.3390/cells13161401
Chicago/Turabian Style
Frydrychowicz, Magdalena, Magdalena Telec, Jacek Anioła, Radosław Kazmierski, Hanna Chowaniec, Grzegorz Dworacki, Izabela Wojtasz, Wojciech Kozubski, and Maria Łukasik.
2024. "The Alteration of Circulating Invariant Natural Killer T, γδT, and Natural Killer Cells after Ischemic Stroke in Relation to Clinical Outcomes: A Prospective Case–Control Study" Cells 13, no. 16: 1401.
https://doi.org/10.3390/cells13161401
APA Style
Frydrychowicz, M., Telec, M., Anioła, J., Kazmierski, R., Chowaniec, H., Dworacki, G., Wojtasz, I., Kozubski, W., & Łukasik, M.
(2024). The Alteration of Circulating Invariant Natural Killer T, γδT, and Natural Killer Cells after Ischemic Stroke in Relation to Clinical Outcomes: A Prospective Case–Control Study. Cells, 13(16), 1401.
https://doi.org/10.3390/cells13161401